More on microembolism and foam sclerotherapy

New England Journal of Medicine

Volumn 359, Issue 6, 2008, Pages 656-657

  Rush, Janet E ^a   Wright, David D I ^a  

^a BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; POLIDOCANOL; VARISOLVE;

BRAIN DAMAGE; BRAIN EMBOLISM; BRAIN INFARCTION; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; GAS EMBOLISM; HEART RIGHT LEFT SHUNT; HUMAN; LETTER; MICROEMBOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SAPHENOUS VEIN; SCLEROTHERAPY; VEIN INSUFFICIENCY;

EID: 49249124999     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080996     Document Type: Letter

References (2)

1. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-6.
2. Regan JD, Gibson KD, Ferris B, et al. Safety of proprietary sclerosant microfoam for saphenous incompetence in patients with R-to-L shunt: interim report. J Vasc Interv Radiol 2008;19:Suppl:S35. abstract.